Skip to main content
Clinical Trials/NCT07832890
NCT07832890Not yet recruitingNot Applicable

Sepsis Associated Liver Injury in Pediatric Patients at Assiut University Children's Hospital: Incidence, Predictors and Clinical Outcomes

Assiut University0 sites158 target enrollmentStarted: September 20, 2026Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
158
Primary Endpoint
Incidence of Sepsis Associated Liver Injury Among Pediatric Sepsis Patients

Study Overview

Brief Summary

This prospective cohort study aims to determine the incidence of sepsis-associated liver injury (SALI) among pediatric patients with sepsis admitted to Assiut University Children's Hospital and to evaluate its association with clinical outcomes.

Detailed Description

Sepsis-associated liver injury (SALI) is associated with poor prognosis in children with sepsis. This observational study will include children aged 1 month to 18 years diagnosed with sepsis according to the Phoenix Sepsis Score (≥2 points).

Patients will be monitored for the development of SALI, defined as ALT ≥2 times the age-specific upper limit of normal and/or total bilirubin >2 mg/dL in the absence of another identifiable cause of liver injury. Clinical outcomes including mortality, PICU admission, length of stay, and need for organ support will be recorded.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
1 Month to 18 Years (Child, Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Age from 1 month to 18 years
  • •Sepsis diagnosed according to the Phoenix Sepsis Score (≥2 points)
  • •Written informed consent from parents or legal guardians

Exclusion Criteria

  • •Neonates less than 28 days of age
  • •Pre-existing chronic liver disease (cirrhosis, biliary atresia, metabolic liver diseases, autoimmune hepatitis, acute viral hepatitis, previous liver transplantation, malignancy with hepatic involvement, or drug-induced liver injury present before admission)

Arms & Interventions

Single cohort: Children with sepsis

Children aged 1 month to 18 years with sepsis according to the Phoenix Sepsis Score who will be monitored for the development of sepsis-associated liver injury and followed for clinical outcomes.

Outcomes

Primary Outcomes

Incidence of Sepsis Associated Liver Injury Among Pediatric Sepsis Patients

Time Frame: 30 days after hospital admission

Proportion of children with sepsis who develop SALI defined as total bilirubin greater than or equal to 4.0 mg per dL or ALT greater than 2 times age-specific upper limit of normal during hospitalization. Calculated as number of SALI cases divided by total number of enrolled sepsis patients

Secondary Outcomes

  • All-Cause Mortality in Children With and Without SALI(30 days after hospital admission)
  • Frequency of PICU Admission(30 days after hospital admission)
  • Duration of PICU Stay(30 days after hospital admission)
  • Hospital Length of Stay(30 days after hospital admission)
  • Need for Mechanical Ventilation(30 days after hospital admission)
  • Need for Vasopressor Therapy(30 days after hospital admission)
  • Incidence of Acute Kidney Injury and MODS(30 days after hospital admission)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Ahmed Osama Ahmed Abd Alhakim

Resident Physician

Assiut University

Similar Trials